共 272 条
[11]
Kraus P(2005)Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism Arch Neurol 62 917-921
[12]
Martinez-Martin P(2006)Robust dysregulation of gene expression in substantia nigra and striatum in Parkinson’s disease Neurobiol Dis 21 305-313
[13]
Morrish P(2006)Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s disease Neurogenetics 7 1-11
[14]
Van Sauten W(2005)Transcriptional analysis of multiple brain regions in Parkinson’s disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms Am J Med Genet B Neuropsychiatr Genet 137 5-16
[15]
Van Hilten B(2009)Mendelian forms of Parkinson’s disease Biochim Biophys Acta 1792 587-596
[16]
Marinus J(2002)Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex Nature 416 703-709
[17]
Visser M(1997)A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p Cell 91 221-230
[18]
Stiggelbout AM(2003)CHIP: a quality-control E3 ligase collaborating with molecular chaperones Int J Biochem Cell Biol 35 572-578
[19]
Rabey JM(2009)Biological fluid biomarkers in neurodegenerative parkinsonism Nat Rev Neurol 5 561-570
[20]
Martinez-Martin P(2010)DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease Brain 133 713-726